Sep 10, 2025 · The FDA has approved a gemcitabine intravesical system for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in …

Jul 7, 2025 · The MHRA has approved a new immunotherapy for BCG-unresponsive bladder cancer, offering a bladder-sparing alternative to cystectomy.

Aug 19, 2025 · High recurrence and evolving treatments highlight advances in AI diagnostics, targeted therapies, biomarkers, and immunotherapy for improved patient outcomes in bladder …

For patients with high-risk superficial bladder cancer, accurate identification of tumor grade and stage are paramount to achieving durable disease control and long-term survival.

Apr 17, 2025 · Anal squamous cell carcinoma (ASCC) is a malignancy arising from the epithelial cells of the anal canal. It is strongly associated with persistent human papillomavirus (HPV) …

Oct 24, 2025 · BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint inhibitor worth it?

Jan 24, 2024 · The future of active surveillance in bladder cancer should involve better patient selection that relies on risk factors, enhanced modalities through imaging and biomarkers, and …

6 days ago · The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.

Dec 5, 2025 · EADV experts urge clinicians to adjust examination techniques and lower biopsy thresholds to improve the diagnosis of inflammatory diseases and cancer in patients with dark …

Jun 21, 2000 · The rest of the random biopsy is consistent with carcinoma in situ. Shall we treat this patient first with bacille Calmette-Guérin (BCG) installations or is a radical cystectomy …